Notify me when Patrick J. Crutcher files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | Common Stock, $0.001 Par Value | 4.2% | $3,593,514 | 549,467 | Patrick J. Crutcher | 06 Aug 2025 | ||
| IBIO | IBIO, INC. | Common Stock | 3.1% | $635,283 | +$112,748 | 847,044 | +22% | Patrick J. Crutcher | 30 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|